CR 2039, a new bis-(1H-tetrazol-5-yl) phenylbenzamide derivative with potential for the topical treatment of asthma-Reference-Cited by-同舟云学术

CR 2039, a new bis-(1H-tetrazol-5-yl) phenylbenzamide derivative with potential for the topical treatment of asthma

Published:1992-12 Issue:1 Volume:229 Page:45-53
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Revel Laura,Colombo Silvia,Ferrari Flora,Folco Giancarlo,Rovati Lucio C.,Makovec Francesco

Publisher

Elsevier BV

Subject

Pharmacology

Reference25 articles.

1. Inflammatory mediators of asthma;Abraham;Pediat. Pulmonol.,1988

2. Inflammatory mediators and asthma;Barnes;Pharmacol. Rev.,1986

3. Rat mast cell hight affinity cyclic nucleotide phosphodiesterases: separation and inhibitory effects of two antiallergic agents;Bergstrand;Mol. Pharmacol.,1978

4. Elevated cyclic AMP levels fail to inhibit extracellular calcium-dependent histamine secretion from rat mast cells;Chabot;Life Sci.,1980

5. The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinica efficacy;Church;Br. J. Pharmacol.,1980

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy?;Expert Opinion on Therapeutic Targets;2015-04-03

2. Andolast Acts at Different Cellular Levels to Inhibit Immunoglobulin E Synthesis;International Journal of Immunopathology and Pharmacology;2009-01

3. Potassium channels as drug targets for therapeutic intervention in respiratory diseases;Expert Opinion on Therapeutic Patents;2008-11-18

4. BK Channel Modulators: A Comprehensive Overview;Current Medicinal Chemistry;2008-05-01

5. Selective Phosphodiesterase Inhibitors in the Treatment of Respiratory Disease;Handbook of Experimental Pharmacology;2004